Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
REVENUES    
Neurometric Services $ 130,900 $ 115,000
OPERATING EXPENSES:    
Cost of Neurometric Service revenues 142,600 132,000
Research 167,900 264,500
Product development 1,119,500 589,200
Sales and marketing 347,500 997,100
General and administrative 2,554,000 2,938,100
Total operating expenses 4,331,500 4,920,900
OPERATING LOSS (4,200,600) (4,805,900)
OTHER INCOME (EXPENSE):    
Interest expense, net (1,288,200) (4,123,200)
Gain on extinguishment of debt 556,300 0
Financing fees (62,100) (151,500)
Offering costs (2,500) (784,100)
Inducement to convert debt (5,792,500) 0
Gain (loss) on derivative liabilities (97,600) 6,950,300
Total other income (expense) (6,686,600) 1,891,500
LOSS BEFORE PROVISION FOR INCOME TAXES (10,887,200) (2,914,400)
Provision for income taxes 800 1,900
LOSS FROM CONTINUING OPERATIONS (10,888,000) (2,916,300)
Loss from discontinued operations (19,400) (490,500)
NET LOSS $ (10,907,400) $ (3,406,800)
BASIC LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (0.14) $ (1.55)
From discontinued operations (in dollars per share) $ 0.00 $ (0.26)
Combined Net Loss (in dollars per share) $ (0.14) $ (1.81)
DILUTED LOSS PER SHARE:    
From continuing operations (in dollars per share) $ (0.14) $ (1.55)
From discontinued operations (in dollars per share) $ 0.00 $ (0.26)
Combined Net Loss (in dollars per share) $ (0.14) $ (1.81)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic (in shares) 75,800,179 1,887,508
Diluted (in shares) 75,800,179 1,887,508